Discover 874 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Indianapolis focus on numerous chronic conditions such as lupus, heart disease, and dystrophy. The city’s leading healthcare institutions are actively recruiting participants seeking paid clinical research opportunities as a healthy volunteer, as well as those looking for studies related to a particular health condition to help advance medical knowledge and treatment options in these critical areas.
Filter
2
Filter results
Results: 874
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
for
Lung Neoplasm
Location: Indianapolis IN, Hines IL, Ann Arbor MI, Milwaukee WI,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT02984761
Recruiting
Options for Pain Management Using Nonpharmacological Strategies
for
Pain
Location: Indianapolis IN
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05563792
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Location: Indianapolis IN, Chicago IL, St Louis MO, Milwaukee WI,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06465810
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
for
Epithelial Ovarian Cancer
Location: Indianapolis IN, Blue Ash OH, Dayton OH, Fort Wayne IN,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT07218809
Phase3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Indianapolis IN, Louisville KY, Zion IL, St Louis MO,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Indianapolis IN, Dayton OH, Louisville KY, Normal IL,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
for
Severe Hypertriglyceridemia
Location: Indianapolis IN, Springfield IL, Ann Arbor MI,
Sponsor: Arrowhead Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06880770
Phase3, Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
for
Endometrial Cancer, Malignant Solid Tumour
Location: Indianapolis IN, Cincinnati OH, Dayton OH,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT07044336
Phase3, Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Indianapolis IN, Cincinnati OH, Lima OH, Versailles KY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Indianapolis IN, Evansville IN, Owensboro KY,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06878261
Phase3, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Indianapolis IN, Richmond IN, Springfield OH,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Indianapolis IN, Cincinnati OH, Champaign IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Indianapolis IN, Richmond IN, Cincinnati OH,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
for
Carcinoma, Non-Small Cell Lung,
Location: Indianapolis IN, Fort Wayne IN, Crown Point IN,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04389632
Phase1, Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
for
Solid Tumours
Location: Indianapolis IN, Maumee OH, Arlington Heights IL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06581432
Phase2, Recruiting
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
for
Head and Neck Carcinoma, Malignant Parotid Gland Neoplasm,
Location: Indianapolis IN, Camden NJ, Jacksonville FL, Houston TX,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04870762
Phase2, Recruiting
Galleri® in the Medicare Population.
for
Cancer
Location: Indianapolis IN, Fishers IN, Anderson IN, Kokomo IN,
Sponsor: GRAIL, Inc.
Sex: All
Age: 50+
Code: NCT05673018
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for
Alzheimer Disease, Dementia, Plaque, Amyloid
Location: Indianapolis IN, Lima OH, Chicago IL, Gainesville GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55+
Code: NCT07602582
Phase3, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Indianapolis IN, Carmel IN, Oak Park IL, Nashville TN,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase2, Recruiting
Locomotor Recovery and Compensation Post-stroke (LRC)